Abstract:Background: Fusion of DNA methyltransferase domains to the nuclease-deficient clustered regularly interspaced short palindromic repeat (CRISPR) associated protein 9 (dCas9) has been used for epigenome editing, but the specificities of these dCas9 methyltransferases have not been fully investigated. Findings: We generated CRISPR-guided DNA methyltransferases by fusing the catalytic domain of DNMT3A or DNMT3B to the C terminus of the dCas9 protein from Streptococcus pyogenes and validated its on-target and global off-target characteristics. Using targeted quantitative bisulfite pyrosequencing, we prove that dCas9-BFP-DNMT3A and dCas9-BFP-DNMT3B can efficiently methylate the CpG dinucleotides flanking its target sites at different genomic loci (uPA and TGFBR3) in human embryonic kidney cells (HEK293T). Furthermore, we conducted whole genome bisulfite sequencing (WGBS) to address the specificity of our dCas9 methyltransferases. WGBS revealed that although dCas9-BFP-DNMT3A and dCas9-BFP-DNMT3B did not cause global methylation changes, a substantial number (more than 1000) of the off-target differentially methylated regions (DMRs) were identified. The off-target DMRs, which were hypermethylated in cells expressing dCas9 methyltransferase and guide RNAs, were predominantly found in promoter regions, 5' untranslated regions, CpG islands, and DNase I hypersensitivity sites, whereas unexpected hypomethylated off-target DMRs were significantly enriched in repeated sequences. Through chromatin immunoprecipitation with massive parallel DNA sequencing analysis, we further revealed that these off-target DMRs were weakly correlated with dCas9 off-target binding sites. Using quantitative polymerase chain reaction, RNA sequencing, and fluorescence reporter cells, we also found that dCas9-BFP-DNMT3A and dCas9-BFP-DNMT3B can mediate transient inhibition of gene expression, which might be caused by dCas9-mediated de novo DNA methylation as well as interference with transcription. Conclusions: Our results prove that dCas9 methyltransferases cause efficient RNA-guided methylation of specific endogenous CpGs. However, there is significant off-target methylation indicating that further improvements of the specificity of CRISPR-dCas9 based DNA methylation modifiers are required.

Allele-specific Genome Editing of Imprinting Genes by Preferentially Targeting Non-Methylated Loci Using Staphylococcus Aureus Cas9 (Sacas9).

Efficient Production of Gene-Modified Mice using Staphylococcus aureus Cas9

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Targeted Gene Disruption by CRISPR/xCas9 System in Drosophila Melanogaster.

CRISPR/dCas9-Tet1-Mediated DNA Methylation Editing.

Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases.

Genome editing with natural and engineered CjCas9 orthologs

Repurposing the CRISPR-Cas9 system for targeted DNA methylation

Locus-Specific and Stable DNA Demethylation at the H19/IGF2 ICR1 by Epigenome Editing Using a dCas9-SunTag System and the Catalytic Domain of TET1

Cas9-orthologue-mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences

Precise Allele-Specific Genome Editing by Spatiotemporal Control of CRISPR-Cas9 Via Pronuclear Transplantation

CRISPR/Cas9-mediated epigenetic editing tool: An optimized strategy for targeting de novo DNA methylation with stable status via homology directed repair pathway

Screening DNA Aptamers That Control the DNA Cleavage, Homology-Directed Repair, and Transcriptional Regulation of the CRISPR-(d)Cas9 System.

Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing.

Efficient Inversions and Duplications of Mammalian Regulatory DNA Elements and Gene Clusters by CRISPR/Cas9

PAM-Flexible Genome Editing with an Engineered Chimeric Cas9.

Editing DNA Methylation in the Mammalian Genome

In vivo genome editing using Staphylococcus aureus Cas9

Engineering of a high-fidelity Cas12a nuclease variant capable of allele-specific editing

Regulation of gene expression by altered promoter methylation using a CRISPR/Cas9-mediated epigenetic editing system